FRY like transcription coactivator (FRYL)

FRY like transcription coactivator (FRYL) is a large, evolutionarily conserved protein involved in regulation of cell polarity, morphogenesis, and transcriptional activation as a coactivator, including with the Notch signaling pathway[1][2][3]. FRYL is expressed in various tissues and is essential for normal development; human loss-of-function variants are associated with neurodevelopmental disorders, congenital anomalies, and intellectual disability[2][3]. In model organisms, its orthologs contribute to cell polarity, dendrite morphogenesis, and maintenance of polarized cell extensions[2][3]. In mice, complete knockout leads to defective renal tubular development, growth retardation, and early lethality, underscoring its role in organogenesis[1]. There is also evidence implicating FRYL in cancer biology, notably as a fusion partner in mixed lineage leukemia[1]. Its precise molecular functions are incompletely understood but may involve regulation of the cytoskeleton, control of microtubule acetylation, and scaffolding for kinases and transcription complexes involved in cell fate decisions[1][2][3][4]. FRYL is not currently recognized as a therapeutic target, and no drugs or established biomarkers exist for clinical targeting or monitoring of this protein.

Other names

Protein furry homolog-likeAF4p12KIAA0826DKFZp686E205MOR2ALL1-fused gene from chromosome 4p12 proteinmor2 cell polarity protein homolog (S. pombe)PCBSfurry-likefurry homolog-likeALL1-fused gene from chromosome 4p12 protein, mor2 cell polarity protein homolog